MARK2 and chronic myelogenous leukemia, BCR-ABL1 positive: The candidate gene identified in this study encoding L-RLK-CML had 53 non-synonymous and 16 synonymous mutations compared with the B73 counterpart Zm00001e041728_T002 encoding B73 v5 L-RLK P2, which was annotated as a G-type lectin S-receptor-like serine/threonine-protein kinase.